CAY10595 structure
|
Common Name | CAY10595 | ||
|---|---|---|---|---|
| CAS Number | 916047-16-0 | Molecular Weight | 451.232 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 810.1±65.0 °C at 760 mmHg | |
| Molecular Formula | C20H13Cl2FN2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 443.8±34.3 °C | |
Use of CAY10595CAY10595 is a potent CRTH2/DP2 receptor antagonist that binds to the human receptor with a Ki of 10 nM. |
| Name | 2-[5-chloro-1'-[(5-chloro-2-fluorophenyl)methyl]-2,2',5'-trioxospiro[indole-3,3'-pyrrolidine]-1-yl]acetic acid |
|---|---|
| Synonym | More Synonyms |
| Description | CAY10595 is a potent CRTH2/DP2 receptor antagonist that binds to the human receptor with a Ki of 10 nM. |
|---|---|
| Related Catalog | |
| Target |
CRTH2/DP2 Receptor:10 nM (Ki) |
| In Vitro | CAY10595 (compound 71) is a potent CRTH2/DP2 receptor antagonist that binds to the human receptor with a Ki of 10 nM[1]. |
| In Vivo | Administration of the DP2 antagonist CAY10595 slightly delays the development of CIA. Treatment with CAY10595 reduces IgG2a anti-CII levels without modification of IgG anti-CII levels[2]. |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 810.1±65.0 °C at 760 mmHg |
| Molecular Formula | C20H13Cl2FN2O5 |
| Molecular Weight | 451.232 |
| Flash Point | 443.8±34.3 °C |
| Exact Mass | 450.018555 |
| PSA | 94.99000 |
| LogP | 3.37 |
| Vapour Pressure | 0.0±3.0 mmHg at 25°C |
| Index of Refraction | 1.705 |
| InChIKey | IXKFWNVFUXXEFY-UHFFFAOYSA-N |
| SMILES | O=C(O)CN1C(=O)C2(CC(=O)N(Cc3cc(Cl)ccc3F)C2=O)c2cc(Cl)ccc21 |
| [5-Chloro-1'-(5-chloro-2-fluorobenzyl)-2,2',5'-trioxospiro[indole-3,3'-pyrrolidin]-1(2H)-yl]acetic acid |
| Spiro-indolinone analogue,71 |
| Spiro[3H-indole-3,3'-pyrrolidine]-1(2H)-acetic acid, 5-chloro-1'-[(5-chloro-2-fluorophenyl)methyl]-2,2',5'-trioxo- |